Ascites-derived pancreatic ductal adenocarcinoma primary cell cultures as a platform for personalised medicine

BACKGROUND: Challenges in developing drugs for pancreatic ductal adenocarcinoma (PDAC) include obtaining metastatic cancer tissue for research and validating biomarkers predicative for personalised therapeutic decisions. We have recently developed a novel therapeutic model for PDAC to address these...

Descripción completa

Detalles Bibliográficos
Autores principales: Golan, T, Atias, D, Barshack, I, Avivi, C, Goldstein, R S, Berger, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007225/
https://www.ncbi.nlm.nih.gov/pubmed/24667644
http://dx.doi.org/10.1038/bjc.2014.123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007225/
https://www.ncbi.nlm.nih.gov/pubmed/24667644
http://dx.doi.org/10.1038/bjc.2014.123

Ejemplares similares